Traynor Capital Management, Inc. Precision Biosciences Inc Transaction History

Traynor Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$1.15 - $3.34 $2,300 - $6,680	-2,000 Reduced 15.38%	11,000 $17,000
Q1 2022 Apr 13, 2022	BUY	$2.96 - $7.76 $5,920 - $15,520	2,000 Added 18.18%	13,000 $40,000
Q1 2021 May 04, 2021	BUY	$8.57 - $15.79 $94,270 - $173,690	11,000 New	11,000 $113,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.